Samuel P. Asper
Impact in
-
- Thyroid Disorders and Treatments
- Thyroid Cancer Diagnosis and Treatment
- Growth Hormone and Insulin-like Growth Factors
- Hormonal and reproductive studies
Papers in
- Anatomy 1
-
- Thyroid Disorders and Treatments 7
- Thyroid Cancer Diagnosis and Treatment 2
- Co-authors
- Herbert A. SelenkowThaddeus E. ProutCharles S. HollanderRichard S. RivlinJohn WiswellJerusha WeaverAndrew HeffernanRobert L. Scott
- Journals
- The American Journal of Medicine (4 papers)The Journal of Clinical Endocrinology & Metabolism (4 papers)New England Journal of Medicine (4 papers)Annals of Internal Medicine (2 papers)JAMA (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Samuel P. Asper
29 papers receiving 264 citations
Peers
Comparison fields: 5 of 88
- Endocrinology, Diabetes and Metabolism 121
- Anatomy 3
- Dermatology 13
- Physiology 37
- Microbiology 1
Countries citing papers authored by Samuel P. Asper
This map shows the geographic impact of Samuel P. Asper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel P. Asper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel P. Asper more than expected).
Fields of papers citing papers by Samuel P. Asper
This network shows the impact of papers produced by Samuel P. Asper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel P. Asper. The network helps show where Samuel P. Asper may publish in the future.
Co-authors
The 20 scholars most cited alongside Samuel P. Asper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 7 | |
| 2 | 1986 | 8 | |
| 3 | Triiodothyronine toxicosis developing during antithyroid drug therapy for hyperthyroidism. | 1972 | 4 |
| 4 | 1969 | 17 | |
| 5 | Insidious fungal disease. A clinicopathological study of secondary aspergillosis. | 1966 | 12 |
| 6 | 1964 | 3 | |
| 7 | INSIDIOUS FUNGAL DISEASE. | 1964 | 7 |
| 8 | 1964 | 8 | |
| 9 | 1963 | 8 | |
| 10 | 1962 | 25 | |
| 11 | 1962 | 7 | |
| 12 | 1961 | 7 | |
| 13 | 1960 | 2 | |
| 14 | 1958 | 9 | |
| 15 | 1958 | 20 | |
| 16 | 1956 | 6 | |
| 17 | 1956 | 11 | |
| 18 | 1955 | 51 | |
| 19 | 1955 | 38 | |
| 20 | 1951 | 1 |
About Samuel P. Asper
Samuel P. Asper is a scholar working on Anatomy, Endocrinology, Diabetes and Metabolism, Biological Psychiatry, Emergency Medical Services and Sensory Systems, having authored 29 papers that have together received 340 indexed citations. Recurring topics across this work include Thyroid Disorders and Treatments (7 papers), Global Health Workforce Issues (2 papers), Cerebral Venous Sinus Thrombosis (2 papers), Ophthalmology and Eye Disorders (2 papers), Medical Education and Admissions (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), Amino Acid Enzymes and Metabolism (1 paper) and Blood properties and coagulation (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (121 citations), Anatomy (3 citations), Dermatology (13 citations), Physiology (37 citations) and Microbiology (1 citation). Samuel P. Asper has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Herbert A. Selenkow, Thaddeus E. Prout, Charles S. Hollander, Richard S. Rivlin, John Wiswell, Jerusha Weaver, Andrew Heffernan, Robert L. Scott, R. I. Levy and David L. Rimoin. Their work appears in journals such as The American Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism, New England Journal of Medicine, Annals of Internal Medicine and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.